Various neurexin transcripts are thought to serve as presynaptic ''hub'' molecules by binding to their specific synaptic partners. In this issue, Zhang et al. demonstrate that neurexins are heparan sulfate (HS) proteoglycans and that the HS modification is important for synaptic function in vitro and in vivo. These findings open up the possibility of many more binding partners for the neurexins.
In the past two decades, many synaptic organizers that directly regulate the formation and functions of synapses have been identified in the central nervous system. Among these, the neurexin (Nrxs) family of cell adhesion proteins has been proposed to serve as major ''hub'' molecules at the presynaptic site and linked to diverse neuropsychiatric and neurodevelopmental disorders, such as schizophrenia and autism (Sü dhof, 2017) . Mammalian Nrxs are encoded by three genes (Nrx1-3), each with three promoters (a, b, and g) and six alternative splicing sites (SS1-SS6) (Figure 1 ). Thousands of alternatively spliced Nrx isoforms (Schreiner et al., 2014; Treutlein et al., 2014) are thought to regulate synapse properties by differentially binding to various postsynaptic membrane proteins, such as neuroligins (NLs), leucinerich repeat transmembrane proteins (LRRTMs), and dystroglycan, as well as secreted proteins, including cerebellins (Cblns) and C1q-like proteins (C1qls). For example, LRRTMs specifically bind to Nrx (SS4-), Cblns bind to Nrx (SS4+), C1qls bind to Nrx3 (SS5 25b ), dystroglycan bind to Nrx (SS2-and SS4-), and IgSF21 bind to Nrx2a (LNS1) (Sü dhof, 2017; Tanabe et al., 2017; Yuzaki, 2018) . Now, Zhang et al., 2018 , this issue of Cell provide compelling evidence that Nrxs themselves are heparan sulfate proteoglycans (HSPGs), joining a superfamily of 17 HSPGs (Xu and Esko, 2014) . Since HSPGs interact with various HS binding proteins (Condomitti and de Wit, 2018) , HS chain-dependent sugar code, in addition to isoform-dependent protein code, likely provide Nrxs with more synaptic binding partners with multifarious functions.
The authors first demonstrate that Nrxs are HSPGs, in which the HS chain is attached to an evolutionally conserved single Ser residue near the transmembrane region (Figure 1 ). When all Nrxs are knocked down, synaptic transmission and development are impaired in cultured hippocampal neurons. These phenotypes are restored by concurrent expression of a mixture of RNAi-resistant Nrx1a and 1b wild-type (Nrx*), but not by a mutant Nrx lacking the HS chain (Nrx*DHS), indicating the requirement of Nrx HS modification for regulation of excitatory and inhibitory synaptic transmission and morphological inhibitory synapse development.
To examine how HS regulates Nrx functions, the authors use COS7 cells expressing NLs or LRRTM2 that are known to induce accumulation of presynaptic markers in axons of co-cultured hippocampal neurons. Knocking down of all Nrxs or heparinase treatment inhibits this accumulation. The effect of Nrx knockdown is rescued by concurrent expression of Nrx*, but not Nrx*DHS. Notably, despite their lack of structural similarity, the authors identified a stretch of positively charged residues (Arg or Lys) in both LRRTMs and NLs that mediate the interaction with the negatively charged HS chain. COS7 cells expressing LRRTM2 or NLs in which Ala replaced these Arg/Lys residues induced much less expression of presynaptic markers in co-cultured hippocampal neurons, indicating that Nrxs HS modification is needed for the synaptogenic activity of LRRTMs and NLs in vitro.
The study further shows that the HS modification on Nrxs is required to regulate synapse induction in vivo in two model organisms. Null mutants in the single Drosophila Nrx dnrx survive but exhibit deficits in synaptic structure and function and locomotion behavior. Neuron-specific expression of Dnrx, but not a version that lacks HS modification, rescues these dnrx null phenotypes. Mice homozygous for a HS-deficient Nrx1 have reduced litter sizes and reduced survival rates after birth. Multiple deficits in pre-and postsynaptic functions are also at mossy fiber-CA3 pyramidal neuron synapses in the hippocampus. Although how such changes impact mouse behaviors involving higher brain functions remains to be clarified, these results clearly indicate the importance of HS modification of Nrxs in vivo.
The authors propose that HS enhances interaction between Nrxs and LRRTMs/ NLs by dual binding mode via the LNS domain and the HS chain on Nrx (Figure 1) . However, the cell-based binding assay using COS7 cells showed that HS-mediated increases in Kd values were relatively modest. Thus, while cell-surface expression of Nrxs is unaffected by HS, HS modification may slow down lateral diffusion of Nrxs on the axonal surface especially at synaptic regions, leading to enhanced synaptogenic activity.
An important question is whether and how HS chains on Nrxs and other HSPGs, such as glypicans and syndecans, differentially bind to more than 300 known HS binding proteins (Xu and Esko, 2014) . For example, although all LRRTMs contain conserved Arg/Lys residues, LRRTM4, but not LRRTM2, binds HS chains on glypicans (de Wit et al., 2013) , indicating that the HS chains on glypicans and Nrxs differentially bind to LRRTM2/4. In addition, it remains unclear whether HS chains on glypicans/syndecans and Nrxs compete for LRRTM4. Furthermore, Nrx HS chains may affect binding of other synaptic organizers, such as Cblns, C1qls, thrombospondin, fibroblast growth factors, ephrins, and type IIA protein tyrosine phosphatases.
Notably, neuronal cell types express unique combinations of HS modifying enzymes (Condomitti and de Wit, 2018) and mutations in genes encoding the HS biosynthetic and modifying enzymes, such as EXT1, HS3ST5, NDST1, and NDST3, are associated with autism susceptibility and neuropsychiatric disorders (Condomitti and de Wit, 2018) . Therefore, HS motifs on Nrxs may contribute to refining synaptic functions in neuronal circuits relevant to these disorders and thus serve as possible new therapeutic targets to correct imbalances in the synaptic pathway.
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